These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 843147)

  • 1. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
    Mookherjee S; Eich RH; Obeid AI; Smulyan H
    Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic effects of propranolol in hypertension: a review.
    Tarazi RC; Dustan HP; Bravo EL
    Postgrad Med J; 1976; 52 Suppl 4():92-100. PubMed ID: 787955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L
    Acta Med Scand Suppl; 1973; 550():1-40. PubMed ID: 4201751
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study on the effects of pindolol and propranolol on systemic and cardiac haemodynamics in hypertensive patients.
    Velasco M; Morillo J; Ramirez A; Hernández E; Vizcarrondo H; Urbin-Aquintana A; López JM; Medrano G; Hernández-Pieretti O
    Int J Clin Pharmacol Res; 1983; 3(2):95-100. PubMed ID: 6384072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamic changes under metoprolol compared to propranolol in hypertensive patients].
    Pfisterer M; Burkart F; Bühler FR; Schweizer W
    Schweiz Med Wochenschr; 1976 Nov; 106(45):1567-9. PubMed ID: 1013675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of nisoldipine in essential hypertension.
    Blau A; Herzog D; Herz I; Battler A; Schechter P; Eliahou HE
    Isr J Med Sci; 1994 Feb; 30(2):139-45. PubMed ID: 8150600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of plasma renin activity and aldosterone levels with hemodynamic functions in essential hypertension.
    London GM; Safar ME; Weiss YA; Corvol PL; Menard JE; Simon AC; Milliez PL
    Arch Intern Med; 1977 Aug; 137(8):1042-7. PubMed ID: 327963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic).
    Aoki K; Sato K
    Arzneimittelforschung; 1982; 32(9):1141-5. PubMed ID: 6756418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity.
    O'Malley K; Velasco M; Wells J; McNay JL
    J Clin Invest; 1975 Feb; 55(2):230-5. PubMed ID: 1127099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of severe hypertension with nifedipine in combination with clonidine or propranolol.
    Imai Y; Abe K; Otsuka Y; Irokawa N; Yasujima M; Saito K; Sakurai Y; Chiba S; Ito T; Sato M; Haruyama T; Miura Y; Yoshinaga K
    Arzneimittelforschung; 1980; 30(4):674-8. PubMed ID: 6994751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the effect of obsidan in essential hypertension patients with different types of circulation].
    Goloshchapov OA; Pribylova NN; Kotova LN; Nozhnova LP
    Ter Arkh; 1986; 58(11):29-32. PubMed ID: 3824185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of propranolol on central hemodynamics in hypertensive patients at rest and during stress].
    Kästner C; Zott HJ; Wallrabe D
    Z Gesamte Inn Med; 1989 Aug; 44(15):442-5. PubMed ID: 2815888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and endocrine changes associated with hypotensive action of amosulalol in essential hypertension.
    Ando K; Noda H; Ogata E; Fujita T
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):7-10. PubMed ID: 1383633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic and biological effects of bromocriptine in essential hypertension].
    Allain H; Daubert JC; Massart C; van den Driessche J; Gouffault J
    Arch Mal Coeur Vaiss; 1982 Sep; 75(9):951-62. PubMed ID: 6816179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposed mechanisms of propranolol's antihypertensive effect in essential hypertension.
    Hollifield JW; Sherman K; Zwagg RV; Shand DG
    N Engl J Med; 1976 Jul; 295(2):68-73. PubMed ID: 775330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-hypertensive action of Captopril. Hemodynamic study (author's transl)].
    Levenson J; Simon A; Temmar M; Safar M
    Nouv Presse Med; 1980 Feb; 9(9):617-9. PubMed ID: 6987622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Exercise hemodynamics and renin before and after acute beta block in patients with essential hypertension].
    Burkart F; Bühler FR; Pfisterer M; Küng M
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1732-5. PubMed ID: 13488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and renal haemodynamics during antihypertensive treatment with propranolol.
    Birkenhäger WH; Krauss XH; Kolsters G; Zaal GA; Schalekamp MA
    Brux Med; 1973 Nov; Spec No(0):183-93. PubMed ID: 4803445
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic effects of guanfacine in essential hypertension.
    Feldstein CA; Cohen AA; Sabaris RP; Burucúa JE
    Clin Ther; 1984; 6(3):325-34. PubMed ID: 6373009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.